1. Rowan T. Chlebowski, MD, PhD, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA; and Aaron K. Aragaki, MS and Ross L. Prentice, PhD, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA